iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Trading Down 0.7% – What’s Next?

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN)’s share price dropped 0.7% during mid-day trading on Monday . The stock traded as low as $25.79 and last traded at $25.79. Approximately 34 shares changed hands during trading, a decline of 97% from the average daily volume of 1,011 shares. The stock had previously closed at $25.98.

iShares Neuroscience and Healthcare ETF Trading Down 0.7 %

The business has a 50-day moving average price of $25.96 and a 200 day moving average price of $25.88. The stock has a market capitalization of $3.87 million, a P/E ratio of 28.31 and a beta of 1.06.

Institutional Investors Weigh In On iShares Neuroscience and Healthcare ETF

A hedge fund recently bought a new stake in iShares Neuroscience and Healthcare ETF stock. Jane Street Group LLC purchased a new position in iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 10,150 shares of the company’s stock, valued at approximately $254,000. Jane Street Group LLC owned 6.77% of iShares Neuroscience and Healthcare ETF as of its most recent filing with the Securities and Exchange Commission.

iShares Neuroscience and Healthcare ETF Company Profile

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap.